Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis

Bridel, Claire, van Wieringen, Wessel N., Zetterberg, Henrik, Tijms, Betty M., Teunissen, Charlotte E., and the NFL Group, Alvarez-Cermeño, José C., Andreasson, Ulf +70 more·2019·JAMA Neurology
DOI 10.1001/jamaneurol.2019.1534

Cited by (771)

Items 601–700 of 771

  1. Physical Activity is Related to Lower Levels of Neurofilament Light and Plasma Tau Protein: A 22-Year Follow-Up Study From Adolescence to Adulthood
    Yasmín Ezzatvar, José Francisco López‐Gil, Rodrigo Alejandro Yañez Sepulveda, Jorge Eduardo Olivares Arancibia, Jacqueline Páez‐Herrera, Antônio García‐Hermoso · 2025 · Journal of Adolescent Health
  2. Longitudinal Changes in Neuroaxonal and Inflammatory CSF Biomarkers in Multiple Sclerosis Patients Undergoing Interferon Beta Therapy
    Simona Petrescu, Maria-Melania Dumitru-Martoiu, Cristina Panea, Charlotte Elisabeth Teunissen · 2025 · Biomedicines
  3. Alcohol consumption and cerebrospinal fluid biomarkers for preclinical alzheimer’s disease in a population-based sample of 70-year-olds
    Silke Kern, Tobias Borgh Skillbäck, Henrik Zetterberg, Anna Dittrich, Felicia Ahlner, Anna Zettergren, Margda Wærn, Nazib M. Seidu, Ulf Andréasson, Kaj Blennow et al. · 2025 · Alzheimer s Research & Therapy
  4. Correlation of Neurodegenerative Biomarkers and Functional Outcome in Patients with Relapsing–Remitting Multiple Sclerosis
    Elīna Polunosika, Monta Feldmane, Daina Pastare, Joel Simrén, Kaj Blennow, Nauris Zdanovskis, Henrik Zetterberg, Renārs Erts, Guntis Karelis · 2025 · Neurology International
  5. Longitudinal changes in cognitive function and its related factors in older type 1 diabetes mellitus patients without dementia
    Kaoru Nagasawa, Kimio Matsumura, Takayasu Uchida, Yuya Suzuki, Akihiro Nishimura, Yukifusa Igeta, Takashi Sakurai, Yasumichi Mori · 2025 · Journal of Diabetes Investigation
  6. The traffic jam hypothesis: Unravelling cellular dysfunctions in Parkinsonism diseases
    Megha Manne, Brijesh Gulabrao Taksande, Milind Janrao Umekar, Madhura Dixit Vinchurney · 2025 · Brain Research
  7. Neurofilament Light Chain as a Biomarker of Disease Progression in Lafora Disease
    Lorenzo Muccioli, Bazile Ganceviciute, Felicitas Becker, Raffaella Minardi, Maria Tappatà, Franziska Bachhuber, Mahmoud Alkhatib, Sebahattin Çırak, Jochen Hans Weishaupt, Mayank Verma et al. · 2025 · Neurology Genetics
  8. Cerebrospinal fluid biomarkers reveal transdiagnostic synaptic dysfunction across major psychiatric disorders
    Andreas Göteson, Johanna Nilsson, Elena Camporesi, Anna Luisa Klahn, Elin Hörbeck, Robert Sigström, Lina Jönsson, Timea Sparding, Erik Pålsson, Aurimantas Pelanis et al. · 2026 · Nature Communications
  9. Neurofilament light chain levels as a biomarker in idiopathic intracranial hypertension: correlations with papilledema and radiological findings
    Ahmed Hamdy, Shimaa Elgamal, Reem Algamal, Hadeer Elsaeed AboElfarh, Muhammad Abdelshafi Elsayed, Ahmed Reda Abdelmeguid Moustafa, Yasmeena Abdelall Kozaa, Hossam Egila, Osama Ahmed Elshafei · 2025 · Acta Neurologica Belgica
  10. The Possible Role of Neurofilament Light Chain as a Serum Biomarker in Anorexia Nervosa: Clinical Implications
    Andrea Amerio, Eleonora Martino, Antonella Strangio, Andrea Aguglia, Benedetta Conio, Samir Giuseppe Sukkar, Danièle Saverino · 2025 · Biomolecules
  11. Integrative analysis of AT classification, plasma biomarkers, and cognitive trajectories across diverse dementia syndromes
    Jihwan Yun, Min Young Chun, Henrik Zetterberg, Kaj Blennow, Fernando González‐Ortiz, Nicholas James Ashton, Daeun Shin, Soyeon Yoon, Heejin Yoo, Jun Pyo Kim et al. · 2025 · Scientific Reports
  12. Factors associated with subjective cognitive complaints in former American football players
    Jennifer S. Adler, Monica T. Ly, Eukyung Yhang, Yorghos Tripodis, Charles H. Adler, Laura Joan Balcer, Charles B. Bernick, Nicholas James Ashton, Henrik Zetterberg, Kaj Blennow et al. · 2026 · Journal of the International Neuropsychological Society
  13. Association between neurofilament light chain concentrations and outcomes in patients with moderate to severe traumatic brain injury: a systematic review and meta-analysis
    Marwan Bouras, Mathieu Pageau, Marc-Aurèle Gagnon, Olivier Costerousse, Karolane Demers, Anouk Grenier-Gagnon, Chartelin Jean Isaac, Tomas Hayg Torkomyan, François Lauzier, Ryan Zarychanski et al. · 2026 · Critical Care
  14. CSF neurofilament light chain concentration in patients with delirium following hip fracture: a multicenter prospective study
    Irit Titlestad, Leiv Otto Watne, Kaj Blennow, Henrik Zetterberg, Marius Myrstad, Emilija Dunjic, Christian Thomas Pollmann, Adi Karabeg, Lene Bergendal Solberg, Ane‐Victoria Idland et al. · 2026 · BMC Geriatrics
  15. Prognostic Determinants of Presentation and Outcome in Anti-IgLON5 Disease
    Lídia Sabater, Mar Guasp, Raquel Ruiz García, Laura Naranjo Rondán, Luís Querol, Lorena Martín-Aguilar, Paula Llarch, Mircea Balasa, Albert Lladó, Cèlia Painous et al. · 2026 · Neurology Neuroimmunology & Neuroinflammation
  16. Application of serum neurofilament light chain (sNfL) and glial fibrillary acidic protein (sGFAP) as biomarkers in the clinical management of multiple sclerosis (NeuroFilMS): a protocol for an observational cohort study
    Rebekka Rust, Sara Samadzadeh, Anna-Lena Röper, Alexander Stahmann, Patrick Schindler, Michael Neumaier, Hans-Werner Rausch, Lucas Schirmer, Jens Kühle, Hayrettin Tumani et al. · 2026 · BMJ Open
  17. Emerging biomarkers for Parkinson's disease in biological fluids
    Petra Bago Rožanković, Goran Šimić · 2026 · Frontiers in Aging Neuroscience
  18. Serum Biomarkers of Neuroaxonal and Astroglial Damage in Autism Spectrum Disorder: Relationship With Symptom Severity, Behavioural Dimensions and Age
    Zeynep Nur Dedeoğlu, Necati Uzun, İbrahim Kılınç, Ahmet Osman Kılıç · 2026 · International Journal of Developmental Neuroscience
  19. CSF Leukocytes Transiently Increase Before Onset of Huntington Disease in Association With a Stage-Specific CSF Cytokine/Chemokine Pattern
    Yu Gao, Birna Ásbjörnsdóttir, Tua Vinther‐Jensen, Marina Rode von Essen, Marie N.N. Hellem, Lena E. Hjermind, Patrick Ejlerskov, G. Bernhard Landwehrmeyer, Finn Thorup Sellebjerg, Jørgen Erik Nielsen et al. · 2026 · Neurology Neuroimmunology & Neuroinflammation
  20. Plasma Neurofilament Light Combined with Risk Genes for the Diagnosis of Alzheimer?s Disease
    S. Z. Zhang, F. Mei, Ming Gao, Li Zhang, Li Ma, Haiyan Wu, L. X. Liu, Min Cao, X. L. He · 2021 · Indian Journal of Pharmaceutical Sciences
  21. Biomarkers in multiple sclerosis
    Cristoforo Comi, Eleonora Virgilio, Domizia Vecchio, Fabiana Tesser, Giuseppe Cappellano · 2023 · Elsevier eBooks
  22. Role of Neurofilament Light Chain as A Biomarker in Neurological Disorders: A Literature Review
    Mohamed Elsayed Abd-ElHady, Imane Yassine, Ehab Ahmed Hashish, Maha Mohamed Anani, Mohamed I. Negm · 2023 · SVOA Neurology
  23. Cerebrospinal Fluid Biomarkers in Huntington’s Disease
    Fabricio Pio, Blair R. Leavitt · 2023 · Contemporary clinical neuroscience
  24. All-Cause Mortality Differentials by Diabetes Status and Serum Neurofilament Light-Chain Levels in US General Adults
    Yingyuan Cai, Qian Wei, Shan Wang, Xiaowei Lu · 2024 · The Journal of Clinical Endocrinology & Metabolism
  25. Translocator protein (TSPO) genotype does not change cerebrospinal fluid levels of glial activation, axonal and synaptic damage markers in early Alzheimer’s disease
    Dominique Gouilly, Agathe Vrillon, Elsa Bertrand, Marie Goubeaud, Hélène Catalá, Johanne Germain, Nadéra Ainaoui, Marie Rafiq, Léonor Nogueira, François Mouton‐Liger et al. · 2024 · NeuroImage Clinical
  26. Cerebrospinal fluid biomarkers and cognitive trajectories in patients with Alzheimer’s disease and a history of traumatic brain injury
    Suzan van Amerongen, Shreyasee Das, Suzie Kamps, Julie Goossens, Bram Bongers, Yolande A.L. Pijnenburg, Eugeen Vanmechelen, Everard G.B. Vijverberg, Charlotte Elisabeth Teunissen, Inge M.W. Verberk · 2024 · Neurobiology of Aging
  27. Biomarkers used in Alzheimer's disease diagnosis
    Shailendra Kumar Mishra, Ritu Singh, Hung‐Ming Chang, Ahmad A. Obaid, Sandeep Kumar Singh · 2024 · Elsevier eBooks
  28. Corticobasal Degeneration and Corticobasal Syndrome
    Gerard Saranza, Melissa J. Armstrong, Anthony Edward Lang · 2025 · Cambridge University Press eBooks
  29. Fluid and Imaging Markers of Frontotemporal Lobar Degeneration
    Fieke Prinse, Julie F. H. De Houwer, Elise G.P. Dopper, Harro Seelaar · 2025 · Springer eBooks
  30. The Relationship Between Human Cerebrospinal Fluid Proteins and the Risk of Delirium: A Study Based on Genetic Data
    Zhihui Xu, Fei Ye, Zhantang Yuan, Chiyi Liu, Simin Zhu, Binfei Li, Qibiao Wu · 2025 · Brain and Behavior
  31. Alzheimer's disease-associated biomarkers in delirium and cognitively normal older adults
    Ane‐Victoria Idland · 2020 · NORA - Norwegian Open Research Archives
  32. Cerebrospinal Fluid Markers of Medium Spiny Neuron Injury in Huntington's Disease
    Jee Bang, Christopher A. Ross · 2021 · Movement Disorders
  33. SARS-CoV-2 spike protein induces TLR-4-mediated long-term cognitive dysfunction recapitulating post-COVID syndrome
    Fabrícia Lima Fontes-Dantas, Gabriel Gripp Fernandes, Elisa Gouvea Gutman, Emanuelle Vasconcellos de Lima, Leticia S. Antonio, Mariana Beiral Hämmerle, Hannah P. Mota-Araujo, Lilian C. Colodeti, Suzana Maria Bernardino Araújo, Talita Nascimento da Silva et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  34. Uman Type NF-L Antibodies Are Effective Reagents for the Imaging of Neurodegeneration
    Gerry Shaw, Irina Madorsky, Ying Li, Yong-Sheng Wang, Sabhya Denise Rana, David Dwight Fuller · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  35. Potential utility of plasma p-tau and NfL as surrogate biomarkers for preventive clinical trials
    Pâmela C.L. Ferreira, João Pedro Ferrari‐Souza, Cécile Tissot, Bruna Bellaver, Douglas Teixeira Leffa, Firoza Zubeida Lussier, Guilherme Povala, Joseph Therriault, Andréa Lessa Benedet, Nicholas James Ashton et al. · 2022 · medRxiv
  36. Addressing inter-individual variability in CSF levels of brain-derived proteins across neurodegenerative diseases
    Sára Mravinacová, Sofia Bergström, Jennie Olofsson, Nerea Gómez de San José, Sarah Anderl‐Straub, Janine Diehl‐Schmid, Klaus C Fassbender, Klaus Fließbach, Holger Jahn, Johannes Kornhuber et al. · 2024 · medRxiv
  37. Higher Serum Neurofilament Light Chain Levels Is Associated with Hypertension: A Cross-Sectional Survey Study
    Xiang Ma, Dilixiati Siti, Kaisaierjiang Kadier, Asiya Abudesimu, Pengfei Liu · 2024 · SSRN Electronic Journal
  38. Stable isotope labeling kinetics of neurofilament light in vitro and in vivo
    Claire Alexandra Leckey, Tatiana A. Giovannucci, John B. Coulton, Yingxin He, Chihiro Sato, Nupur Ghoshal, Tharini Vignarajah, Zane Jaunmuktane, Nicolas R. Barthélemy, Henrik Zetterberg et al. · 2025 · medRxiv
  39. Associations between Cardiovascular Risk Factors and Neurofilament Light Levels Among U.S. Mexican American Adults
    Monica Maria Diaz, Eran Dayan, the Health and Aging Brain Study: Health Disparities (HABS-HD) Team · 2025 · medRxiv
  40. The Alzheimer disease continuum : findings from monogenic Alzheimer disease
    Charlotte Johansson · 2025
  41. Effects of Diminished Cerebrospinal Fluid Flow in the Spinal Canal on Amyloid Pathophysiology in Vervet Monkeys
    Jeongchul Kim, Megan E. Lipford, Richard A. Barcus, Brett M. Frye, Hongyu Yuan, Qing Lyu, Jeremy Patton Hudson, Samuel Neal Lockhart, Courtney L. Sutphen, Thomas C. Register et al. · 2025 · Research Square
  42. Muscle Proteins in Plasma Associate to Distinguished Phenotypes in Amyotrophic Lateral Sclerosis
    Louisa Azizi, Inci Sevval Aksoylu, María Bueno Álvez, Juliette Foucher, Alexander Juto, Christina Seitz, Raymond Press, Kristin Samuelsson, Ulf Kläppe, Mathias Uhlén et al. · 2026 · SSRN Electronic Journal
  43. Development of Sandwich Assays for Potential Protein Biomarkers in Neurodegenerative Diseases
    Jamil Yousef · 2020 · KTH Publication Database DiVA (KTH Royal Institute of Technology)
  44. Diagnostic précoce et biomarqueurs biologiques de la maladie d'Alzheimer
    Claire Paquet · 2020 · NPG. Neurologie, psychiatrie, gériatrie/NPG
  45. Comparison of cerebrospinal fluid biomarkers relevant to neurodegenerative diseases in healthy cynomolgus and rhesus macaque monkeys
    Emma L. Robertson, Susan E. Boehnke, Natalia M. Lyra e Silva, Brittney Armitage‐Brown, Andrew Winterborn, Douglas J. Cook, Fernanda G. De Felice, Douglas P. Munoz · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  46. CSF Biomarkers in Down Syndrome and Autosomal Dominant Alzheimer Disease
    Anne M. Fagan, Rachel L. Henson, Yan Li, Anna H. Boerwinkle, Chengjie Xiong, Randall John Bateman, Alison Goate, Beau M. Ances, Eric W. Doran, Bradley T. Christian et al. · 2021 · SSRN Electronic Journal
  47. The role of neurofilament light chain in the context of neurological disorders
    Vera Taluntienė, R. Motiekaitytė, Rasa Kizlaitienė, Nataša Giedraitienė, Gintaras Kaubrys · 2020 · Neurologijos seminarai
  48. Characterizing Neurodegenerative Disease Biomarkers in Cerebrospinal Fluid of Non-human Primates
    Emma Robertson · 2021 · QSpace (Queen's University Library)
  49. Фармакоэпидемиологические аспекты приверженности врачей лечебно-профилактических учреждений Орла назначению антигипертензивных препаратов
    Г. И. Швец, Sergey V. Povetkin · 2008 · Рациональная фармакотерапия в кардиологии
  50. Kue gurih nusantara / Hindah Muaris; editor Intarina Hardiman
    Hindah Muaris · 2003
  51. Performance of plasma amyloid, tau, and astrocyte biomarkers to identify cerebral AD pathophysiology
    Pâmela C.L. Ferreira, Cécile Tissot, João Pedro Ferrari‐Souza, Wagner Scheeren Brum, Bruna Bellaver, Douglas Teixeira Leffa, Joseph Therriault, Andréa Lessa Benedet, Firoza Zubeida Lussier, Mira Chamoun et al. · 2022 · medRxiv
  52. Neurofilament-Leichtketten (NFL) als prognostischer Biomarker in der Diagnostik der multiplen Sklerose
    Gerhard Maximilian Oremek, K. Passek, Markus Braun, Janis Dröge, Daniela Ohlendorf · 2022 · Zentralblatt für Arbeitsmedizin Arbeitsschutz und Ergonomie
  53. Rapport 22-06. Maladies neurodégénératives : marqueurs biologiques et de neuroimagerie
    François Chollet, Bernard H. Bioulac, Bruno Dubois, Jean‐Jacques Hauw, Jean‐Marc Léger · 2022 · Bulletin de l Académie Nationale de Médecine
  54. Preclinical study of Therapeutic application of Sertoli Cells transplantation for treatment of Neurodegenerative Diseases: A Systematic Review
    Houssein Ahmadi, Leila Mehboudi, Dorsa Vatandoust, Robabeh Asadi, Abdollah Amini · 2022 · Research Square
  55. Frauengesundheit – Frauenmedizin
    2023 · Elsevier eBooks
  56. Geschlechtsspezifische Besonderheiten zu ausgewählten Gesundheitsthemen
    2023 · Elsevier eBooks
  57. From CoNFLict to Confidence: Solving a Diagnostic Dilemma Using Neurofilament Light – A Case Report
    Paula M. Loveland, Dhamidhu Eratne, Sarah Holper, Nawaf Yassi, Rosie Watson · 2023 · European Medical Journal
  58. Brain Changes in Diabetes and Cognitive Dysfunction
    Geert Jan Biessels · 2023 · Contemporary diabetes
  59. Search for Molecular Biomarkers of Parkinson’s Disease. New Tissues and Methods
    Peter Račay · 2023 · Acta Medica Martiniana
  60. Šarko-Marī-Tūta slimības klīnisko izpausmju dažādība un tās saistība ar neirofilamentu un ģenētisko tipu. Promocijas darba kopsavilkums
    Elina Kalnina · 2023
  61. Šarko-Marī-Tūta slimības klīnisko izpausmju dažādība un tās saistība ar neirofilamentu un ģenētisko tipu. Promocijas darbs
    Elina Kalnina · 2023
  62. Clinical Variability of Charcot-Marie-Tooth Disease and its Association with Neurofilament and Genetic Type of Disease. Summary of the Doctoral Thesis
    Elina Kalnina · 2023
  63. Blood and CSF Biomarkers in Autosomal Dominant Cerebellar Ataxias
    Giulia Coarelli, Alexandra Dürr · 2023 · Contemporary clinical neuroscience
  64. Contemporary diagnosis of Alzheimer's disease: IImportance of different biomarkers
    Elka D. Stefanova · 2023 · Galenika Medical Journal
  65. Continuing the search for fluid biomarkers to enhance Huntington's disease staging and therapeutic response
    Eilrayna Gelyana, Rebecca Khamishon, Jee Bang · 2024 · Journal of the Neurological Sciences
  66. Additional file 2 of The circadian rest-activity pattern predicts cognitive decline among mild-moderate Alzheimer’s disease patients
    Adriano Targa, Ivan David Benitez, Farida Dakterzada, John Fontenele Araújo, Olga Mínguez, Henrik Zetterberg, Kaj Blennow, Ferrán Barbé, Gerard Piñol‐Ripoll · 2021 · Figshare
  67. Additional file 1 of Association of CSF proteins with tau and amyloid β levels in asymptomatic 70-year-olds
    Julia Remnestål, Sofia Bergström, Jennie Olofsson, Evelina Sjöstedt, Mathias Uhlén, Kaj Blennow, Henrik Zetterberg, Anna Zettergren, Silke Kern, Ingmar Gr. Skoog et al. · 2021 · Figshare
  68. Additional file 1 of The circadian rest-activity pattern predicts cognitive decline among mild-moderate Alzheimer’s disease patients
    Adriano Targa, Ivan David Benitez, Farida Dakterzada, John Fontenele Araújo, Olga Mínguez, Henrik Zetterberg, Kaj Blennow, Ferrán Barbé, Gerard Piñol‐Ripoll · 2021 · Figshare
  69. Additional file 3 of The circadian rest-activity pattern predicts cognitive decline among mild-moderate Alzheimer’s disease patients
    Adriano Targa, Ivan David Benitez, Farida Dakterzada, John Fontenele Araújo, Olga Mínguez, Henrik Zetterberg, Kaj Blennow, Ferrán Barbé, Gerard Piñol‐Ripoll · 2021 · Figshare
  70. Additional file 5 of The circadian rest-activity pattern predicts cognitive decline among mild-moderate Alzheimer’s disease patients
    Adriano Targa, Ivan David Benitez, Farida Dakterzada, John Fontenele Araújo, Olga Mínguez, Henrik Zetterberg, Kaj Blennow, Ferrán Barbé, Gerard Piñol‐Ripoll · 2021 · Figshare
  71. Additional file 7 of The circadian rest-activity pattern predicts cognitive decline among mild-moderate Alzheimer’s disease patients
    Adriano Targa, Ivan David Benitez, Farida Dakterzada, John Fontenele Araújo, Olga Mínguez, Henrik Zetterberg, Kaj Blennow, Ferrán Barbé, Gerard Piñol‐Ripoll · 2021 · Figshare
  72. Additional file 4 of The circadian rest-activity pattern predicts cognitive decline among mild-moderate Alzheimer’s disease patients
    Adriano Targa, Ivan David Benitez, Farida Dakterzada, John Fontenele Araújo, Olga Mínguez, Henrik Zetterberg, Kaj Blennow, Ferrán Barbé, Gerard Piñol‐Ripoll · 2021 · Figshare
  73. Diagnosis of Alzheimer's disease and other neurodegenerative diseases using cerebrospinal fluid and blood-based biomarkers
    Martin Vyhnálek, Kateřina Veverová · 2024 · Neurologie pro praxi
  74. Serum neurofilament light chain levels as multiple sclerosis biomarker
    Mohamed Elsayed Abd-ElHady, Ehab Ahmed Hashish, Imane Yassine, Maha Mohamed Anani, Mohamed Negm · 2024 · Progress in Neurology and Psychiatry
  75. The Current Research Status of Neurofilament Light Chains in Neurological Diseases
    元浩 高 · 2024 · Advances in Clinical Medicine
  76. Neurofilaments light chains as a diagnostic and predictive biomarker for Tunisian Multiple Sclerosis patients
    Saloua Mrabet, Ikram Sghaier, Amira Souissi, Alya Gharbi, Youssef Abida, Imen Kacem, Amina Gargouri, Riadh Gouider · 2024 · Multiple Sclerosis and Related Disorders
  77. Revisiting sex-gender disparities in MSA: An unfinished narrative
    Alexandra Pérez‐Soriano, Cèlia Painous, Bàrbara Segura, Marı́a José Martı́ · 2024 · Parkinsonism & Related Disorders
  78. Serum neurofilament light chain in response to probiotics in bi-center, double-blind, randomized, placebo-controlled clinical trial (CleverAge Biota)
    L Fialová, Aleš Bartoš, Marta Kalousová, Libuše Nosková, Miroslava Zelenková, Michaela Slukova, Tomáš Zima · 2024 · Biomedical Papers
  79. Apathy and Affective Symptoms Associated with Elevated Alzheimer’s Disease Biomarkers
    Matthew JY Kang, Dhamidhu Eratne, Samantha M. Loi, Christa Dang, Alexander Frizell Santillo, Henrik Zetterberg, Kaj Blennow, Philip Bowden Mitchell, Malcolm Hopwood, Charles Benjamin Malpas et al. · 2024 · medRxiv
  80. Higher serum neurofilament light chain levels is associated with hypertension: new discoveries with old disease
    Asiya Abudesimu, Kaisaierjiang Kadier, Dilixiati Siti, Pengfei Liu, Xiang Ma · 2024 · Research Square
  81. Evaluation of neurofilament light chain levels in multiple sclerosis during acute attack periods
    Alp Sarıteke, Levent Öcek, İnanç Karakoyun, Ayfer Çolak, Ufuk ŞENER · 2024 · Çukurova medical journal (Online)/Çukurova medical journal
  82. New Research on Biomarkers in Alzheimer’s Continuum
    Immacolata Vecchio, Carmela Colica · 2025 · Reviews on Recent Clinical Trials
  83. Neurofilament Light Chain: A Potential Diagnostic Biomarker for Rabies
    Nayana Siddalingaiah, Lonika Lodha, Ashwini Manoor Ananda, Shubhangi Chandel, Sathya Priya Manuel, Parthipulli Vasuki Prathyusha, Tina Damodar, Sarada Subramanian, Reeta Subramaniam Mani · 2025 · Microbiology and Immunology
  84. Advances in fluid-based biomarkers
    Henrik Zetterberg · 2025 · Elsevier eBooks
  85. Gekommen, um zu bleiben - die Rolle von Serum-NfL als Biomarker
    Marc Pawlitzki, Lars Masanneck, Ramona Hagler, Orhan Aktaş, Stefan Bittner, David Leppert, Pascal Benkert, Michael Khalil, Iris Wittner, Andy Jones et al. · 2025 · NeuroTransmitter
  86. Marqueurs biologiques des maladies neurodégénératives
    Agathe Vrillon, Clément Aveneau, Claire Paquet · 2025 · Encyclopédie médico-chirurgicale. Neurologie
  87. Nogo-A and NfL Levels in CSF from Newly Diagnosed Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder Patients Positive for Anti-HHV6-A IgG Autoantibody
    Şeyda Karabörk, Bihter Gökçe Çelik, Firdevs Uluç, Şule Aydın Türkoğlu, Serpil Yıldız · 2025 · Journal of Clinical Medicine
  88. Effects of proinflammatory cytokines and programmed cell death on cognitive domains in older age patients with bipolar disorder
    Pei-Ying Lee, Chih Chiang Chiu, Po‐Hsiu Kuo, Cho‐Yin Huang, Shang‐Ying Tsai, Chian‐Jue Kuo, Wen-Yin Chen · 2025 · Annals of General Psychiatry
  89. Increased serum Neurofilament light chain levels in Parkinson’s Disease patients carrying the p.A53T SNCA mutation: Data from the PPMI study
    Nikolaos Papagiannakis, Christos Koros, Athina-Maria Simitsi, Leonidas Stefanis, The Parkinson’s Progression Markers Initiative · 2025 · medRxiv
  90. Serum Metabolomic Profiling in Possible Early-Stage Multiple Sclerosis: A Targeted 1H-NMR Comparison of OCB Type 1 and Type 2 Patterns
    Pınar Şengül, Ahmet Tarık Baykal, Mustafa Serteser · 2025 · Journal of Molecular Neuroscience
  91. Novel SQSTM1 (c.838G>T) Mutation Identified in Two Unrelated Cases of Cerebellar Ataxia and Gaze Palsy
    Neda Hoseini, Azin Momeni, Amir Bahreini · 2025 · Advanced Biomedical Research
  92. Cerebrospinal Fluid, Molecular Neuroimaging, and Blood Biomarkers of Neurodegenerative Disease: Past, Present, and Future
    David N. Soleimani‐Meigooni, Gil Dan Rabinovici · 2025 · Cambridge University Press eBooks
  93. Association between cognitive function, socio-clinical factors and biomarkers among Panamanian adults living with and without HIV: A cross-sectional study
    Juan Castillo Mewa, Julissa Moreno, Lia Nadir Caballero, Marggie Rodríguez, Alberto Cumbrera, Cecilio Niño, Juan Miguel Pascale, Alcibiades E. Villarreal, Lissette R. Chang, Ana Belén Araúz et al. · 2025 · Scientific Reports
  94. Multimodal Biomarker Characterization of the ALS/FTD Spectrum: A Real-World Clinical Dataset Analysis
    Sasha Mukhija, Lisa Hering, Simon J. Schreiner, Franz Lehner, Jan Loosli, Claudio Togni, Ferdinand Otto, Mario Ziegler, Tobias Weiß, Hans Heinrich Jung et al. · 2025 · International Journal of Molecular Sciences
  95. Limited predictive value of preoperative nigrosome integrity for motor outcomes in Parkinson’s disease deep brain stimulation
    Chao‐Kai Hu, Walaa B. Mohammed, Yutong Bai, Franziska Schmidt, Tiffany A. Rodrigues, Suneil Kumar Kalia, Alfonso A. Fasano, Jürgen Germann, Paula Alcaide Leon, Alexandre Boutet et al. · 2025 · npj Parkinson s Disease
  96. Additional file 1 of Age and sex impact plasma NFL and t-Tau trajectories in individuals with subjective memory complaints: a 3-year follow-up study
    Filippo Baldacci, Simone Lista, Manca, Maria Laura, Patrizia Andrea Chiesa, Enrica Cavedo, Pablo Lemercier, Henrik Zetterberg, Kaj Blennow, Marie‐Odile Habert, Marie‐Claude Potier et al. · 2020 · Figshare
  97. Additional file 9 of Association of CSF proteins with tau and amyloid β levels in asymptomatic 70-year-olds
    Julia Remnestål, Sofia Bergström, Jennie Olofsson, Evelina Sjöstedt, Mathias Uhlén, Kaj Blennow, Henrik Zetterberg, Anna Zettergren, Silke Kern, Ingmar Gr. Skoog et al. · 2021 · Figshare
  98. Additional file 6 of Association of CSF proteins with tau and amyloid β levels in asymptomatic 70-year-olds
    Julia Remnestål, Sofia Bergström, Jennie Olofsson, Evelina Sjöstedt, Mathias Uhlén, Kaj Blennow, Henrik Zetterberg, Anna Zettergren, Silke Kern, Ingmar Gr. Skoog et al. · 2021 · Figshare
  99. Additional file 3 of Association of CSF proteins with tau and amyloid β levels in asymptomatic 70-year-olds
    Julia Remnestål, Sofia Bergström, Jennie Olofsson, Evelina Sjöstedt, Mathias Uhlén, Kaj Blennow, Henrik Zetterberg, Anna Zettergren, Silke Kern, Ingmar Gr. Skoog et al. · 2021 · Figshare
  100. Additional file 1 of Altered plasma protein profiles in genetic FTD – a GENFI study
    Abbe Ullgren, Linn Öijerstedt, Jennie Olofsson, Sofia Bergström, Julia Remnestål, John Cornelis Van Swieten, Lize Corrine Jiskoot, Harro Seelaar, Barbara Borroni, Raquel Sánchez‐Valle et al. · 2024 · Figshare